ACURA PHARMACEUTICALS, INC SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KACURA PHARMACEUTICALS, INCACUROct 8

   Acura Pharmaceuticals secures $100K loan

   • Received $100,000 loan on 10/2/2026
   • Total principal balance is $11,294,279 as of 9/30/2026
   • Accrued interest of $1,365,000 as of 9/30/2026
2. NOTABLENT 10-QACURA PHARMACEUTICALS, INCACURAug 26

   Late quarterly report notice

3. ROUTINE8-KACURA PHARMACEUTICALS, INCACURAug 20

   Current report

4. ROUTINE8-KACURA PHARMACEUTICALS, INCACURJul 24

   Current report

5. ROUTINE8-KACURA PHARMACEUTICALS, INCACURJun 29

   Current report

6. NOTABLENT 10-QACURA PHARMACEUTICALS, INCACURMay 13

   Late quarterly report notice

7. ROUTINE8-KACURA PHARMACEUTICALS, INCACURMay 7

   Current report

8. NOTABLENT 10-KACURA PHARMACEUTICALS, INCACURMar 27

   Late annual report notice

9. ROUTINE8-KACURA PHARMACEUTICALS, INCACURMar 10

   Current report

10. ROUTINE8-KACURA PHARMACEUTICALS, INCACURJan 20

    Current report

11. ROUTINE4ACURA PHARMACEUTICALS, INCACURJan 15

    3 insider filings

    Immanuel Thangaraj, insider filing for ACUR

    Show all 3

    • 4Insider filing for ACURJan 15
    • 4Insider filing for ACURJan 15
    • 4Insider filing for ACURJan 15

    Immanuel Thangaraj, reporting

12. ROUTINE8-KACURA PHARMACEUTICALS, INCACURDec 29, 2025

    Current report

13. NOTABLENT 10-QACURA PHARMACEUTICALS, INCNov 21, 2025

    Late quarterly report notice

Older filings on EDGAR